A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 08 2021
Historique:
received: 03 08 2020
accepted: 16 07 2021
entrez: 12 8 2021
pubmed: 13 8 2021
medline: 24 8 2021
Statut: epublish

Résumé

The Netrin-1 receptor UNC5B is an axon guidance regulator that is also expressed in endothelial cells (ECs), where it finely controls developmental and tumor angiogenesis. In the absence of Netrin-1, UNC5B induces apoptosis that is blocked upon Netrin-1 binding. Here, we identify an UNC5B splicing isoform (called UNC5B-Δ8) expressed exclusively by ECs and generated through exon skipping by NOVA2, an alternative splicing factor regulating vascular development. We show that UNC5B-Δ8 is a constitutively pro-apoptotic splicing isoform insensitive to Netrin-1 and required for specific blood vessel development in an apoptosis-dependent manner. Like NOVA2, UNC5B-Δ8 is aberrantly expressed in colon cancer vasculature where its expression correlates with tumor angiogenesis and poor patient outcome. Collectively, our data identify a mechanism controlling UNC5B's necessary apoptotic function in ECs and suggest that the NOVA2/UNC5B circuit represents a post-transcriptional pathway regulating angiogenesis.

Identifiants

pubmed: 34381052
doi: 10.1038/s41467-021-24998-6
pii: 10.1038/s41467-021-24998-6
pmc: PMC8358048
doi:

Substances chimiques

NOVA2 protein, human 0
Nerve Tissue Proteins 0
Netrin Receptors 0
Neuro-Oncological Ventral Antigen 0
RNA Isoforms 0
RNA-Binding Proteins 0
Netrin-1 158651-98-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4872

Informations de copyright

© 2021. The Author(s).

Références

Elife. 2016 May 25;5:
pubmed: 27223325
Nucleic Acids Res. 2016 Jan 4;44(D1):D1018-22
pubmed: 26602693
Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):887-93
pubmed: 12067894
FASEB J. 2002 Jun;16(8):833-41
pubmed: 12039865
Cold Spring Harb Perspect Biol. 2010 May;2(5):a001875
pubmed: 20452960
Mol Cell. 2009 Mar 27;33(6):692-703
pubmed: 19328064
Cell. 1992 Oct 16;71(2):289-99
pubmed: 1384987
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13254-9
pubmed: 9789075
Cell Rep. 2014 May 22;7(4):1211-26
pubmed: 24813895
Blood. 2006 Oct 1;108(7):2339-48
pubmed: 16794251
Nat Genet. 2008 Dec;40(12):1413-5
pubmed: 18978789
Neuron. 2015 Jul 1;87(1):14-27
pubmed: 26139367
Curr Opin Struct Biol. 2013 Jun;23(3):443-50
pubmed: 23706950
Cell Mol Life Sci. 2017 Dec;74(24):4387-4403
pubmed: 28646366
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1076-81
pubmed: 15644447
Proteomics. 2004 Apr;4(4):995-1006
pubmed: 15048981
Mol Cancer. 2017 Jan 30;16(1):8
pubmed: 28137272
Nucleic Acids Res. 2011 Jul;39(12):4961-74
pubmed: 21355037
Semin Cell Dev Biol. 2014 Aug;32:30-6
pubmed: 24657195
Curr Opin Genet Dev. 2011 Feb;21(1):73-9
pubmed: 21106363
Circ Res. 2000 Sep 15;87(6):434-9
pubmed: 10988233
Dev Cell. 2019 Apr 22;49(2):279-292.e5
pubmed: 31014480
Blood. 2012 Mar 1;119(9):2159-70
pubmed: 22246030
Dev Cell. 2015 Jul 6;34(1):5-17
pubmed: 26151903
Cell Death Differ. 2009 Oct;16(10):1344-51
pubmed: 19543238
Mol Cell. 2019 Oct 17;76(2):329-345
pubmed: 31626751
Development. 2008 Feb;135(4):659-67
pubmed: 18223200
Cardiovasc Res. 2003 May 1;58(2):378-89
pubmed: 12757872
Hum Mutat. 2012 Jan;33(1):81-5
pubmed: 21922594
Blood. 2004 Nov 1;104(9):2761-6
pubmed: 15242875
Dev Biol. 2001 Dec 1;240(1):123-42
pubmed: 11784051
Science. 2003 Nov 14;302(5648):1212-5
pubmed: 14615540
Oncogene. 2018 Feb 1;37(5):627-637
pubmed: 28991230
Biol Reprod. 2005 Mar;72(3):727-35
pubmed: 15564598
Genes Dev. 2007 Oct 1;21(19):2433-47
pubmed: 17908930
PLoS One. 2011;6(6):e21242
pubmed: 21695058
J Exp Clin Cancer Res. 2020 Dec 7;39(1):275
pubmed: 33287867
J Cell Sci. 2001 Aug;114(Pt 15):2755-73
pubmed: 11683410
Nature. 2016 Aug 11;536(7615):215-8
pubmed: 27487218
Cancer Res. 2005 Dec 15;65(24):11529-35
pubmed: 16357162
Nature. 2006 Nov 30;444(7119):580-6
pubmed: 17065982
Gene Expr. 2007;13(6):321-7
pubmed: 17708418
Nat Commun. 2015 Apr 30;6:6993
pubmed: 25925867
J Clin Invest. 2014 Oct;124(10):4335-50
pubmed: 25157817
Int J Cancer. 1994 May 1;57(3):419-26
pubmed: 8169005
Cancer Cell. 2018 Aug 13;34(2):211-224.e6
pubmed: 30078747
Mol Biol Cell. 2002 Apr;13(4):1175-89
pubmed: 11950930
Dev Biol. 2002 Aug 15;248(2):307-18
pubmed: 12167406
Onco Targets Ther. 2018 Sep 20;11:6049-6056
pubmed: 30275709
Nucleic Acids Res. 2013 Oct;41(18):8665-79
pubmed: 23863836
Nature. 2004 Nov 11;432(7014):179-86
pubmed: 15510105
Cancer Cell. 2012 Jul 10;22(1):91-105
pubmed: 22789541
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
Nature. 2008 Nov 27;456(7221):470-6
pubmed: 18978772
Cancer Cell. 2013 Jul 8;24(1):130-7
pubmed: 23810565
Mol Cell. 2010 Dec 22;40(6):863-76
pubmed: 21172653
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13759-64
pubmed: 16945906
Mol Cancer Res. 2012 May;10(5):605-14
pubmed: 22522454
Trends Genet. 2005 Feb;21(2):73-7
pubmed: 15661351
Nat Chem Biol. 2018 May;14(5):458-465
pubmed: 29507390
Dev Cell. 2009 Apr;16(4):614-20
pubmed: 19386270
Nucleic Acids Res. 2018 Jan 4;46(D1):D950-D955
pubmed: 29088455
Bio Protoc. 2021 Apr 20;11(8):e3998
pubmed: 34124299
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Nat Rev Cancer. 2016 Jul;16(7):413-30
pubmed: 27282250
BMC Cancer. 2014 Dec 17;14:970
pubmed: 25518851
Immunol Rev. 2013 May;253(1):216-36
pubmed: 23550649
Blood. 2009 Apr 2;113(14):3363-70
pubmed: 19196664
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):911-2
pubmed: 12740225
J Cell Physiol. 2009 May;219(2):449-58
pubmed: 19180561
Neuron. 2014 Oct 22;84(2):370-85
pubmed: 25374360
Mol Cell Biol. 1997 Jun;17(6):3194-201
pubmed: 9154818
Cells. 2019 Nov 23;8(12):
pubmed: 31771184
Nat Commun. 2015 Oct 08;6:8479
pubmed: 26446569
Genome Res. 2017 Oct;27(10):1759-1768
pubmed: 28855263
Oncogene. 2014 Nov 13;33(46):5311-8
pubmed: 24336324
Science. 2014 Jun 13;344(6189):1275-9
pubmed: 24876346
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8390-5
pubmed: 16717195
Mol Cell. 2011 Aug 5;43(3):353-68
pubmed: 21816343
Curr Top Dev Biol. 2008;80:1-55
pubmed: 17950371
Elife. 2018 Jan 02;7:
pubmed: 29293084
BMC Genomics. 2018 May 29;19(1):405
pubmed: 29843604
J Proteome Res. 2004 Jan-Feb;3(1):76-83
pubmed: 14998166
J Cell Physiol. 2011 Jul;226(7):1750-62
pubmed: 21506107
Acta Neuropathol Commun. 2019 Aug 19;7(1):133
pubmed: 31426859
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W361-7
pubmed: 24829458
Genome Res. 2011 Oct;21(10):1572-82
pubmed: 21846794
RNA. 2014 Feb;20(2):189-201
pubmed: 24335142
PLoS Genet. 2007 Oct;3(10):1838-47
pubmed: 17937501
Dev Biol. 2001 Feb 15;230(2):278-301
pubmed: 11161578
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Angiogenesis. 2003;6(3):171-83
pubmed: 15041793
BMC Bioinformatics. 2006 Apr 17;7:208
pubmed: 16618368
Elife. 2019 Mar 04;8:
pubmed: 30829570
J Cell Physiol. 1999 Mar;178(3):359-70
pubmed: 9989782
Cell Death Differ. 2019 Oct;26(10):1987-1997
pubmed: 30683914
Exp Cell Res. 1998 May 1;240(2):197-205
pubmed: 9596992
J Pathol. 2003 Nov;201(3):395-403
pubmed: 14595751
J Cell Sci. 2005 Feb 1;118(Pt 3):623-32
pubmed: 15657074
Anal Biochem. 2016 Jan 1;492:8-12
pubmed: 26399556
Int J Cell Biol. 2013;2013:962038
pubmed: 24285959
Methods. 2014 Feb;65(3):274-87
pubmed: 24184352
EMBO J. 2005 Mar 23;24(6):1192-201
pubmed: 15729359
Microvasc Res. 2002 Sep;64(2):334-8
pubmed: 12204657
Cardiovasc Res. 2021 Jan 1;117(1):256-270
pubmed: 31999325
Cell Mol Life Sci. 2017 Sep;74(17):3205-3224
pubmed: 28601983
Gene Expr Patterns. 2013 Dec;13(8):311-8
pubmed: 23806443
Neoplasia. 2004 Jan-Feb;6(1):1-6
pubmed: 15068665
Nucleic Acids Res. 2003 Jul 1;31(13):3701-8
pubmed: 12824398
J Cancer Res Clin Oncol. 2002 Oct;128(10):533-8
pubmed: 12384796
EMBO J. 2001 Jun 1;20(11):2715-22
pubmed: 11387206
Nature. 2000 Sep 14;407(6801):249-57
pubmed: 11001068
Development. 2016 Aug 15;143(16):2973-82
pubmed: 27471260
Skelet Muscle. 2018 Mar 6;8(1):8
pubmed: 29510724
Biochemistry. 2012 Jul 17;51(28):5541-56
pubmed: 22708632

Auteurs

Davide Pradella (D)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", Consiglio Nazionale delle Ricerche, Pavia, Italy.
Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Gianluca Deflorian (G)

IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
Cogentech, Società Benefit, Milan, Italy.

Alex Pezzotta (A)

Department of Medical Biotechnology and Translational Medicine, University of Milan-LITA, Segrate, Italy.

Anna Di Matteo (A)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", Consiglio Nazionale delle Ricerche, Pavia, Italy.

Elisa Belloni (E)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", Consiglio Nazionale delle Ricerche, Pavia, Italy.

Daniele Campolungo (D)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", Consiglio Nazionale delle Ricerche, Pavia, Italy.
IRCCS San Raffaele Scientific Institute, Division of Genetics and Cell Biology, Milan, Italy.

Andrea Paradisi (A)

Apoptosis, Cancer and Development Laboratory - Equipe labellisée "La Ligue", LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, France.

Mattia Bugatti (M)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

William Vermi (W)

Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Matteo Campioni (M)

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Antonella Chiapparino (A)

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.
Heidelberg University Biochemistry Center (BZH), INF 328, Heidelberg, Germany.

Luigi Scietti (L)

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Federico Forneris (F)

The Armenise-Harvard Laboratory of Structural Biology, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy.

Costanza Giampietro (C)

IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
Swiss Federal Laboratories for Materials Science and Technology, Experimental Continuum Mechanics EMPA, Dübendorf, Switzerland.

Nina Volf (N)

Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), AREA Science Park, Padriciano 99, Trieste, Italy.

Michael Rehman (M)

Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), AREA Science Park, Padriciano 99, Trieste, Italy.
Yale University School of Medicine, Section of Nephrology, New Haven, CT, USA.

Serena Zacchigna (S)

Cardiovascular Biology Laboratory, International Centre for Genetic Engineering and Biotechnology (ICGEB), AREA Science Park, Padriciano 99, Trieste, Italy.
Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.

Maria Paola Paronetto (MP)

Laboratory of Molecular and Cellular Neurobiology, IRCCS Santa Lucia Foundation, Rome, Italy.
Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy.

Anna Pistocchi (A)

Department of Medical Biotechnology and Translational Medicine, University of Milan-LITA, Segrate, Italy.

Anne Eichmann (A)

Cardiovascular Research Center, Yale University School of Medicine, Department of Internal Medecine Cardiology, New Haven, CT, USA.
INSERM U970, Paris Center for Cardiovascular Research (PARCC), Paris, France.
Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.

Patrick Mehlen (P)

Apoptosis, Cancer and Development Laboratory - Equipe labellisée "La Ligue", LabEx DEVweCAN, Centre de Recherche en Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Université Claude Bernard Lyon1, Centre Léon Bérard, Lyon, France.

Claudia Ghigna (C)

Istituto di Genetica Molecolare "Luigi Luca Cavalli-Sforza", Consiglio Nazionale delle Ricerche, Pavia, Italy. Claudia.Ghigna@igm.cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH